<DOC>
	<DOC>NCT00398099</DOC>
	<brief_summary>To collect clinical response data with the use of ertapenem in approved indications.</brief_summary>
	<brief_title>To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-052)</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Ertapenem</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Male or female patients, 20 years of age or older Patients did not receive any systemic antibiotic before enrollment, or patients with failed clinical response (no improvement on symptoms or laboratory data) through previous antibiotic treatment Patients who required therapy prior to identification of cause of infection Patient has a concomitant infection that may interfere with the evaluation of the response to ertapenem Patient has an apache ii &gt; 30. Patient has an infection caused by pathogens resistant to ertapenem Patients with known allergy to ertapenem or other drugs in the same carbapenem class, beta lactams, lidocaine or local anesthetics of the amide type The patient requires antibiotics other than ertapenem (such as: glycopeptides, macrolides or antifungal agents)</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>